Nova Eye Medical Ltd
ASX:EYE
Nova Eye Medical Ltd
ASX:EYE
Price:
0.17
AUD
Market Closed
Market Cap:
AU$48.4m
Balance Sheet
Balance Sheet Decomposition
Nova Eye Medical Ltd
Nova Eye Medical Ltd
Balance Sheet Decomposition is not available for
Nova Eye Medical Ltd
Nova Eye Medical Ltd
Balance Sheet
Nova Eye Medical Ltd
Nova Eye Medical Ltd
Currency: AUD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
5
|
7
|
9
|
23
|
15
|
96
|
18
|
8
|
7
|
6
|
5
|
|
| Cash Equivalents |
5
|
7
|
9
|
23
|
15
|
96
|
18
|
8
|
7
|
6
|
5
|
|
| Total Receivables |
12
|
15
|
15
|
15
|
16
|
4
|
5
|
4
|
3
|
4
|
4
|
|
| Accounts Receivables |
12
|
15
|
15
|
15
|
15
|
2
|
2
|
2
|
2
|
4
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
4
|
2
|
1
|
0
|
0
|
|
| Inventory |
16
|
19
|
23
|
22
|
26
|
3
|
3
|
4
|
4
|
4
|
3
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
34
|
43
|
49
|
61
|
58
|
103
|
26
|
16
|
15
|
15
|
12
|
|
| PP&E Net |
4
|
8
|
13
|
15
|
14
|
3
|
4
|
3
|
2
|
4
|
3
|
|
| PP&E Gross |
4
|
8
|
13
|
0
|
14
|
3
|
4
|
3
|
2
|
4
|
3
|
|
| Accumulated Depreciation |
7
|
9
|
9
|
0
|
11
|
1
|
1
|
1
|
2
|
2
|
3
|
|
| Intangible Assets |
15
|
16
|
17
|
19
|
19
|
11
|
12
|
18
|
13
|
11
|
11
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
6
|
5
|
7
|
9
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
59
N/A
|
72
+22%
|
87
+20%
|
103
+20%
|
100
-3%
|
117
+17%
|
42
-64%
|
37
-13%
|
30
-17%
|
30
-2%
|
27
-11%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
4
|
5
|
4
|
6
|
4
|
4
|
2
|
2
|
4
|
4
|
2
|
|
| Accrued Liabilities |
4
|
5
|
5
|
0
|
5
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
6
|
6
|
15
|
9
|
15
|
0
|
1
|
1
|
1
|
0
|
1
|
|
| Other Current Liabilities |
2
|
2
|
3
|
7
|
5
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
16
|
19
|
28
|
23
|
29
|
14
|
5
|
4
|
6
|
6
|
5
|
|
| Long-Term Debt |
1
|
2
|
0
|
6
|
0
|
1
|
2
|
1
|
1
|
3
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
3
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
19
N/A
|
24
+24%
|
30
+25%
|
30
+2%
|
31
+3%
|
16
-48%
|
7
-59%
|
6
-6%
|
7
+15%
|
9
+19%
|
8
-12%
|
|
| Equity | ||||||||||||
| Common Stock |
41
|
46
|
56
|
78
|
78
|
78
|
37
|
37
|
45
|
53
|
59
|
|
| Retained Earnings |
0
|
3
|
2
|
5
|
11
|
25
|
1
|
6
|
22
|
30
|
40
|
|
| Other Equity |
1
|
0
|
1
|
0
|
2
|
2
|
2
|
1
|
0
|
1
|
0
|
|
| Total Equity |
40
N/A
|
48
+21%
|
57
+18%
|
73
+29%
|
69
-6%
|
101
+46%
|
35
-65%
|
30
-14%
|
23
-24%
|
21
-8%
|
19
-11%
|
|
| Total Liabilities & Equity |
59
N/A
|
72
+22%
|
87
+20%
|
103
+20%
|
100
-3%
|
117
+17%
|
42
-64%
|
37
-13%
|
30
-17%
|
30
-2%
|
27
-11%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
108
|
114
|
121
|
144
|
144
|
144
|
148
|
150
|
195
|
229
|
284
|
|
Switch to:
Switch to:
See Also
Discover More
